FLUVASTATIN Side Effects

7007403-X | Dementia
on Sep 09, 2010 Male patient from JAPAN , 69 years of age, was treated with Fluvastatin (View Usage). Patient experienced the following unwanted or unexpected effects: dementia (What is dementia?). Fluvastatin dosage: . During the same period patient was treated with DIOVAN (View Diovan Review and Diovan Label ).

6979103-3 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Condition Aggravated, Gamma-glutamyltransferase Increased, Liver Disorder, Photocoagulation
Patient was taking Fluvastatin (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, condition aggravated, gamma-glutamyltransferase increased, liver disorder, photocoagulation on Aug 31, 2010 from JAPAN Additional patient health information: Female patient , weighting 99.21 lb, was diagnosed with dyslipidaemia, rhinitis allergic and. Fluvastatin dosage: 20 Mg Daily. During the same period patient was treated with FLUORESCEIN SODIUM (Unk) (View Fluorescein Sodium Review and Fluorescein Sodium Label ), INDOCYANINE GREEN (Unk) (View Indocyanine Green Review and Indocyanine Green Label ), CETIRIZINE HYDROCHLORIDE (10 Mg) (View Cetirizine Hydrochloride Review and Cetirizine Hydrochloride Label ).

6966818-6 | Liver Disorder, Photocoagulation
Adverse event was reported on Aug 24, 2010 by a Female patient taking Fluvastatin (View Usage) (Dosage: 20 Mg Daily) was diagnosed with dyslipidaemia and. Location: JAPAN , 83 years of age, After Fluvastatin was administered, patient had the following side effects: liver disorder, photocoagulation. During the same period patient was treated with FLUORESCEIN SODIUM (Unk) (View Fluorescein Sodium Review and Fluorescein Sodium Label ), INDOCYANINE GREEN (Unk) (View Indocyanine Green Review and Indocyanine Green Label ), CETIRIZINE HYDROCHLORIDE (20 Mg) (View Cetirizine Hydrochloride Review and Cetirizine Hydrochloride Label ), URSO 250 (600 Mg) (View Urso 250 Review and Urso 250 Label ).

6905989-4 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Eosinophil Count Increased, Gamma-glutamyltransferase Increased, Liver Disorder
on Jul 21, 2010 Female patient from JAPAN , 60 years of age, was diagnosed with hypercholesterolaemia and was treated with Fluvastatin (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, eosinophil count increased, gamma-glutamyltransferase increased, liver disorder. Fluvastatin dosage: 20 Mg, Qd.


6895545-9 | Anaphylactic Shock, Atrial Fibrillation, Blood Pressure Increased, Cardiac Arrest
on Jul 27, 2010 Male patient from JAPAN , weighting 163.1 lb, was diagnosed with hypercholesterolaemia, pharyngitis and was treated with Fluvastatin (View Usage). Patient had the following side effects: anaphylactic shock, atrial fibrillation (What is atrial fibrillation?), blood pressure increased, cardiac arrest (What is cardiac arrest?). Fluvastatin dosage: 30 Mg, Unk. During the same period patient was treated with FIRSTCIN (1 G, Unk) (View Firstcin Review and Firstcin Label ), BLOPRESS (12 Mg, Unk) (View Blopress Review and Blopress Label ), ASPIRIN (Unk) (View Aspirin Review and Aspirin Label ), PLAVIX (75 Mg, Unk) (View Plavix Review and Plavix Label ), ZYLORIC (100 Mg, Unk) (View Zyloric Review and Zyloric Label ). Patient was hospitalized.

6862134-1 | Decreased Appetite, Eosinophil Count Increased, Hepatic Function Abnormal, Liver Disorder, Malaise, Pyrexia
Patient was taking Fluvastatin (View Usage). After Fluvastatin was administered, patient had the following side effects: decreased appetite, eosinophil count increased, hepatic function abnormal, liver disorder, malaise, pyrexia on Jul 06, 2010 from JAPAN Additional patient health information: Female patient , weighting 112.4 lb, was diagnosed with hypertension and. Fluvastatin dosage: Unk. During the same period patient was treated with AMLODIPINE (5 Mg) (View Amlodipine Review and Amlodipine Label ), LONGES (10 Mg) (View Longes Review and Longes Label ). Patient was hospitalized.

6802906-2 | Accidental Exposure, Dizziness, Eyelid Oedema, Somnolence
Adverse event was reported on Jun 14, 2010 by a Female patient taking Fluvastatin (View Usage) (Dosage: 60 Mg Daily) . Location: JAPAN , child 2 years of age, Patient experienced the following unwanted or unexpected effects: accidental exposure, dizziness (What is dizziness?), eyelid oedema, somnolence. During the same period patient was treated with GOODMIN (Unk) (View Goodmin Review and Goodmin Label ), LENDORMIN (Unk) (View Lendormin Review and Lendormin Label ). Patient was hospitalized.

6795495-2 | C-reactive Protein Increased, Cough, Dyspnoea, Interstitial Lung Disease, Productive Cough, Pyrexia, Rhinorrhoea
on Jun 15, 2010 Male patient from JAPAN , weighting 134.5 lb, was diagnosed with dyslipidaemia, hypertension, diabetes mellitus, pruritus and was treated with Fluvastatin (View Usage). Patient had the following side effects: c-reactive protein increased, cough, dyspnoea, interstitial lung disease, productive cough, pyrexia, rhinorrhoea. Fluvastatin dosage: 20 Mg Daily. During the same period patient was treated with FLUVASTATIN SODIUM (Unk) (View Fluvastatin Sodium Review and Fluvastatin Sodium Label ), RENIVACE (5 Mg, Unk) (View Renivace Review and Renivace Label ), ENALAPRIL MALEATE (5 Mg, Unk) (View Enalapril Maleate Review and Enalapril Maleate Label ), AMARYL (4 Mg, Unk) (View Amaryl Review and Amaryl Label ), ACTOS (15 Mg, Unk) (View Actos Review and Actos Label ), ALLELOCK (5 Mg, Unk) (View Allelock Review and Allelock Label ), DERMIZOL G (Unk) (View Dermizol G Review and Dermizol G Label ), ZINC OXIDE (Unk) (View Zinc Oxide Review and Zinc Oxide Label ). Patient was hospitalized.

6789848-6 | Anaphylactic Shock, Atrial Fibrillation, Blood Pressure Increased, Cardiac Arrest
on Jun 22, 2010 Male patient from JAPAN , weighting 163.1 lb, was diagnosed with hypercholesterolaemia, pharyngitis and was treated with Fluvastatin (View Usage). After Fluvastatin was administered, patient had the following side effects: anaphylactic shock, atrial fibrillation (What is atrial fibrillation?), blood pressure increased, cardiac arrest (What is cardiac arrest?). Fluvastatin dosage: 30 Mg, Unk. During the same period patient was treated with FIRSTCIN (1 G, Unk) (View Firstcin Review and Firstcin Label ), BLOPRESS (12 Mg, Unk) (View Blopress Review and Blopress Label ), ASPIRIN (Unk) (View Aspirin Review and Aspirin Label ), PLAVIX (75 Mg, Unk) (View Plavix Review and Plavix Label ), ZYLORIC (100 Mg, Unk) (View Zyloric Review and Zyloric Label ). Patient was hospitalized.

6789834-6 | Eosinophilic Pneumonia, Erythema Annulare, Pyrexia, Rash
Patient was taking Fluvastatin (View Usage). Patient experienced the following unwanted or unexpected effects: eosinophilic pneumonia, erythema annulare, pyrexia, rash (What is rash?) on Jun 11, 2010 from JAPAN Additional patient health information: Male patient , 78 years of age, . Fluvastatin dosage: Unk.

6789824-3 | Acute Myocardial Infarction, Angina Pectoris, Coronary Arterial Stent Insertion, Coronary Artery Disease, Dyspnoea, Stent Placement
Adverse event was reported on Jun 11, 2010 by a Male patient taking Fluvastatin (View Usage) (Dosage: 80 Mg/d) was diagnosed with hyperlipidaemia, hypertension, coronary artery disease (What is coronary artery disease?) and. Location: GERMANY , weighting 196.2 lb, Patient had the following side effects: acute myocardial infarction, angina pectoris, coronary arterial stent insertion, coronary artery disease (What is coronary artery disease?), dyspnoea, stent placement. During the same period patient was treated with NO TREATMENT RECEIVED NOMED (View No Treatment Received Nomed Review and No Treatment Received Nomed Label ), RAMIPRIL (10 Mg/d) (View Ramipril Review and Ramipril Label ), ASPIRIN (100mg/d) (View Aspirin Review and Aspirin Label ), ISCOVER (45 Mg/d) (View Iscover Review and Iscover Label ), BISOPROLOL (5 Mg/d) (View Bisoprolol Review and Bisoprolol Label ), BETA BLOCKING AGENTS (Unk) (View Beta Blocking Agents Review and Beta Blocking Agents Label ), BISOHEXAL (5 Mg/d) (View Bisohexal Review and Bisohexal Label ), OLMESARTAN MEDOXOMIL (20 Mg/d) (View Olmesartan Medoxomil Review and Olmesartan Medoxomil Label ). Patient was hospitalized.

6774462-9 | Liver Disorder
on Jun 07, 2010 Female patient from JAPAN , 60 years of age, was diagnosed with hypercholesterolaemia and was treated with Fluvastatin (View Usage). After Fluvastatin was administered, patient had the following side effects: liver disorder. Fluvastatin dosage: 20 Mg, Qd.

6767486-9 | Eosinophilic Pneumonia, Erythema Annulare
on Jun 02, 2010 Male patient from JAPAN , 78 years of age, was treated with Fluvastatin (View Usage). Patient experienced the following unwanted or unexpected effects: eosinophilic pneumonia, erythema annulare. Fluvastatin dosage: Unk.

6766104-3 | Convulsion, Muscle Spasms
Patient was taking Fluvastatin (View Usage). Patient had the following side effects: convulsion, muscle spasms on Jun 01, 2010 from JAPAN Additional patient health information: Female patient , 72 years of age, was diagnosed with hypercholesterolaemia and. Fluvastatin dosage: 20 Mg, Unk.

6751307-4 | C-reactive Protein Increased, Cough, Dyspnoea, Interstitial Lung Disease, Productive Cough, Pyrexia, Rhinorrhoea
Adverse event was reported on May 19, 2010 by a Male patient taking Fluvastatin (View Usage) (Dosage: 20 Mg Daily) was diagnosed with dyslipidaemia, hypertension, diabetes mellitus, pruritus and. Location: JAPAN , weighting 134.5 lb, After Fluvastatin was administered, patient had the following side effects: c-reactive protein increased, cough, dyspnoea, interstitial lung disease, productive cough, pyrexia, rhinorrhoea. During the same period patient was treated with FLUVASTATIN SODIUM (Unk) (View Fluvastatin Sodium Review and Fluvastatin Sodium Label ), RENIVACE (5 Mg, Unk) (View Renivace Review and Renivace Label ), ENALAPRIL (5 Mg, Unk) (View Enalapril Review and Enalapril Label ), AMARYL (4 Mg, Unk) (View Amaryl Review and Amaryl Label ), ACTOS (15 Mg, Unk) (View Actos Review and Actos Label ), ALLELOCK (5 Mg, Unk) (View Allelock Review and Allelock Label ), DERMIZOL G (Unk) (View Dermizol G Review and Dermizol G Label ), ZINC OXIDE (Unk) (View Zinc Oxide Review and Zinc Oxide Label ). Patient was hospitalized.

6713167-7 | C-reactive Protein Increased, Cough, Pneumonitis
on Apr 23, 2010 Male patient from JAPAN , 68 years of age, was diagnosed with hyperlipidaemia and was treated with Fluvastatin (View Usage). Patient experienced the following unwanted or unexpected effects: c-reactive protein increased, cough, pneumonitis. Fluvastatin dosage: 20 Mg Daily. During the same period patient was treated with FLUVASTATIN SODIUM (Unk) (View Fluvastatin Sodium Review and Fluvastatin Sodium Label ). Patient was hospitalized.

6707962-8 | Liver Disorder
on Apr 20, 2010 Female patient from JAPAN , 60 years of age, was diagnosed with hypercholesterolaemia and was treated with Fluvastatin (View Usage). Patient had the following side effects: liver disorder. Fluvastatin dosage: 20 Mg, Qd.

6707958-6 | Abdominal Pain Upper, Back Pain, Jaundice, Liver Disorder, Lymphocyte Stimulation Test Positive
Patient was taking Fluvastatin (View Usage). After Fluvastatin was administered, patient had the following side effects: abdominal pain upper, back pain (What is back pain?), jaundice (What is jaundice?), liver disorder, lymphocyte stimulation test positive on Apr 20, 2010 from JAPAN Additional patient health information: Female patient , weighting 123.5 lb, was diagnosed with dyslipidaemia, liver disorder and. Fluvastatin dosage: 20 Mg Daily. During the same period patient was treated with URSO 250 (View Urso 250 Review and Urso 250 Label ). Patient was hospitalized.

6679520-5 | Back Pain, Hypoaesthesia, Muscular Weakness, Musculoskeletal Pain, Sleep Disorder
Adverse event was reported on Apr 01, 2010 by a Male patient taking Fluvastatin (View Usage) (Dosage: 30 Mg Per Day) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: JAPAN , weighting 147.7 lb, Patient experienced the following unwanted or unexpected effects: back pain (What is back pain?), hypoaesthesia, muscular weakness, musculoskeletal pain, sleep disorder (What is sleep disorder?). During the same period patient was treated with REBETOL (4 Df, Unk) (View Rebetol Review and Rebetol Label ), PEG INTRON (80 Ug, Unk) (View Peg-intron Review and Peg-intron Label ).

6679476-5 | Acute Myocardial Infarction, Angina Pectoris, Coronary Arterial Stent Insertion, Coronary Artery Disease, Hypertension, Percutaneous Coronary Intervention, Stent Placement
on Mar 31, 2010 Male patient from GERMANY , weighting 196.2 lb, was diagnosed with hyperlipidaemia, hypertension, coronary artery disease (What is coronary artery disease?) and was treated with Fluvastatin (View Usage). Patient had the following side effects: acute myocardial infarction, angina pectoris, coronary arterial stent insertion, coronary artery disease (What is coronary artery disease?), hypertension, percutaneous coronary intervention, stent placement. Fluvastatin dosage: 80 Mg/d. During the same period patient was treated with NO TREATMENT RECEIVED NOMED (View No Treatment Received Nomed Review and No Treatment Received Nomed Label ), RAMIPRIL (10 Mg/d) (View Ramipril Review and Ramipril Label ), ASPIRIN (100mg/d) (View Aspirin Review and Aspirin Label ), ISCOVER (45 Mg/d) (View Iscover Review and Iscover Label ), BISOPROLOL (5 Mg/d) (View Bisoprolol Review and Bisoprolol Label ), BETA BLOCKING AGENTS (Unk) (View Beta Blocking Agents Review and Beta Blocking Agents Label ). Patient was hospitalized.

6676490-0 | Blood Creatine Phosphokinase Increased, Blood Pressure Decreased, Brain Stem Infarction, Decreased Appetite, Decubitus Ulcer, Dehydration, Pain, Rhabdomyolysis
on Apr 06, 2010 Male patient from JAPAN , 80 years of age, was diagnosed with dyslipidaemia and was treated with Fluvastatin (View Usage). After Fluvastatin was administered, patient had the following side effects: blood creatine phosphokinase increased, blood pressure decreased, brain stem infarction, decreased appetite, decubitus ulcer, dehydration, pain (What is pain?), rhabdomyolysis. Fluvastatin dosage: Unk.

6643173-2 | Blood Creatine Phosphokinase Increased, Gait Disturbance, Inflammation, Pneumonia, Pyrexia
Patient was taking Fluvastatin (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatine phosphokinase increased, gait disturbance, inflammation, pneumonia (What is pneumonia?), pyrexia on Mar 10, 2010 from JAPAN Additional patient health information: Female patient , 84 years of age, was diagnosed with hypercholesterolaemia and. Fluvastatin dosage: 20 Mg Daily. Patient was hospitalized.

6290727-1 | Myalgia
Adverse event was reported on Jul 29, 2009 by a Male patient taking Fluvastatin (View Usage) (Dosage: 20 Mg At Bedtime Po) was diagnosed with hyperlipidaemia and. Location: UNITED STATES , 85 years of age, weighting 212.0 lb, Patient had the following side effects: myalgia.

6194083-9 | Transaminases Increased
on May 11, 2009 Female patient from GERMANY , 64 years of age, weighting 141.1 lb, was diagnosed with hypercholesterolaemia, type 2 diabetes mellitus and was treated with Fluvastatin (View Usage). After Fluvastatin was administered, patient had the following side effects: transaminases increased. Fluvastatin dosage: 80 Mg, Qd, Oral. During the same period patient was treated with METFORMIN HCL (1000 Mg, Bid, Oral) (View Metformin Hcl Review and Metformin Hcl Label ), BYETTA (5 Ug, Bid, Subcutaneous) (View Byetta Review and Byetta Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), LERCANIDIPINE (View Lercanidipine Review and Lercanidipine Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ). Patient was hospitalized.

6108408-3 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Creatinine Increased, Blood Fibrinogen Increased, Continuous Haemodiafiltration, Fall, Hyperkalaemia, Hypoglycaemia, International Normalised Ratio Increased
on Mar 02, 2009 Male patient from GERMANY , 76 years of age, was diagnosed with hypercholesterolaemia, type 2 diabetes mellitus, prophylaxis, hypertension, hypothyroidism and was treated with Fluvastatin (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatinine increased, blood fibrinogen increased, continuous haemodiafiltration, fall (What is fall?), hyperkalaemia, hypoglycaemia, international normalised ratio increased. Fluvastatin dosage: 80 Mg, Qd. During the same period patient was treated with AMARYL (1mg Per Day) (View Amaryl Review and Amaryl Label ), ASPIRIN (100mg Per Day) (View Aspirin Review and Aspirin Label ), DELIX (2.5mg Per Day) (View Delix Review and Delix Label ), METFORMIN (1000mg 2 In Day) (View Metformin Review and Metformin Label ), BELOC ZOK (View Beloc Zok Review and Beloc Zok Label ), BERLTHYROX (75ug Per Day) (View Berlthyrox Review and Berlthyrox Label ).

5939901-1 | Dyspnoea
Patient was taking Fluvastatin (View Usage). Patient had the following side effects: dyspnoea on Oct 30, 2008 from UNITED STATES Additional patient health information: Male patient , 64 years of age, weighting 188.0 lb, was diagnosed with hyperlipidaemia and. Fluvastatin dosage: 20 Mg At Bedtime Po.

5937108-5 | Arthralgia, Blood Cholesterol Increased, Collagen Disorder, Lipids Increased, Low Density Lipoprotein Increased, Oedema
Adverse event was reported on Oct 22, 2008 by a Female patient taking Fluvastatin (View Usage) (Dosage: 40 Mg, Qd) was diagnosed with hyperlipidaemia and. Location: GERMANY , weighting 136.7 lb, After Fluvastatin was administered, patient had the following side effects: arthralgia, blood cholesterol increased, collagen disorder, lipids increased, low density lipoprotein increased, oedema. During the same period patient was treated with HORMONES AND RELATED AGENTS (View Hormones And Related Agents Review and Hormones And Related Agents Label ).

5888901-9 | Blood Creatine Phosphokinase Increased, Myoglobin Blood Increased
on Sep 12, 2008 Male patient from JAPAN , 64 years of age, was diagnosed with hypercholesterolaemia, hypertension and was treated with Fluvastatin (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatine phosphokinase increased, myoglobin blood increased. Fluvastatin dosage: 30 Mg, Qd. During the same period patient was treated with TANATRIL (10 Mg) (View Tanatril Review and Tanatril Label ), BLOPRESS (8 Mg) (View Blopress Review and Blopress Label ), ARTIST (10 Mg) (View Artist Review and Artist Label ).

5877577-2 | Deep Vein Thrombosis, White Blood Cell Count Decreased
on Sep 02, 2008 Female patient from JAPAN , 75 years of age, was diagnosed with hypercholesterolaemia and was treated with Fluvastatin (View Usage). Patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), white blood cell count decreased. Fluvastatin dosage: 20 Mg, Qd. During the same period patient was treated with NU LOTAN (50 Mg, Unk) (View Nu-lotan Review and Nu-lotan Label ). Patient was hospitalized.

5877019-7 | Blood Potassium Increased
Patient was taking Fluvastatin (View Usage). After Fluvastatin was administered, patient had the following side effects: blood potassium increased on Sep 02, 2008 from JAPAN Additional patient health information: Male patient , 73 years of age, was diagnosed with hypercholesterolaemia and. Fluvastatin dosage: 30mg, Qd. During the same period patient was treated with LIPITOR (Unk) (View Lipitor Review and Lipitor Label ), PLAVIX (View Plavix Review and Plavix Label ), PHENOBARBITAL TAB (View Phenobarbital Tab Review and Phenobarbital Tab Label ), SELENICA R (View Selenica-r Review and Selenica-r Label ), SERMION (View Sermion Review and Sermion Label ).

5875896-7 | Alanine Aminotransferase Abnormal, Aspartate Aminotransferase Abnormal, Hepatic Failure
Adverse event was reported on Aug 25, 2008 by a Female patient taking Fluvastatin (View Usage) (Dosage: 20 Mg, Qd) was diagnosed with lipids abnormal and. Location: JAPAN , 59 years of age, Patient experienced the following unwanted or unexpected effects: alanine aminotransferase abnormal, aspartate aminotransferase abnormal, hepatic failure.

5859121-9 | Gynaecological Examination Abnormal, Hepatic Function Abnormal
on Aug 20, 2008 Female patient from JAPAN , 62 years of age, was diagnosed with hypercholesterolaemia and was treated with Fluvastatin (View Usage). Patient had the following side effects: gynaecological examination abnormal, hepatic function abnormal. Fluvastatin dosage: . During the same period patient was treated with ALLEGRA (View Allegra Review and Allegra Label ). Patient was hospitalized.

5851721-5 | Hospitalisation, White Blood Cell Count Decreased
on Aug 05, 2008 Female patient from JAPAN , 75 years of age, was diagnosed with hypercholesterolaemia and was treated with Fluvastatin (View Usage). After Fluvastatin was administered, patient had the following side effects: hospitalisation, white blood cell count decreased. Fluvastatin dosage: 20 Mg, Qd. During the same period patient was treated with NU LOTAN (50 Mg, Unk) (View Nu-lotan Review and Nu-lotan Label ), WARFARIN SODIUM (3.5 Unk, Unk) (View Warfarin Sodium Review and Warfarin Sodium Label ). Patient was hospitalized.

5845168-5 | Blood Creatine Phosphokinase Increased, Fasciitis, Myositis, Oedema Peripheral, Pain In Extremity
Patient was taking Fluvastatin (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatine phosphokinase increased, fasciitis, myositis (What is myositis?), oedema peripheral, pain in extremity on Aug 07, 2008 from JAPAN Additional patient health information: Male patient , 65 years of age, was diagnosed with lipids abnormal and. Fluvastatin dosage: 20mg Per Day. Patient was hospitalized.

5843277-8 | Cardiac Arrest, Diarrhoea, Vomiting
Adverse event was reported on Aug 23, 2006 by a Male patient taking Fluvastatin (View Usage) (Dosage: ) was diagnosed with hypercholesterolaemia, angina pectoris, hypertension and. Location: JAPAN , weighting 116.8 lb, Patient had the following side effects: cardiac arrest (What is cardiac arrest?), diarrhoea, vomiting. During the same period patient was treated with FASTIC (Unk) (View Fastic Review and Fastic Label ), NITOROL (View Nitorol Review and Nitorol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), AMARYL (View Amaryl Review and Amaryl Label ), NIVADIL (View Nivadil Review and Nivadil Label ), DAONIL (View Daonil Review and Daonil Label ), BUFFERIN (View Bufferin Review and Bufferin Label ), VASOLATOR (View Vasolator Review and Vasolator Label ).

5843170-0 | Retinal Haemorrhage, Visual Acuity Reduced
on Jul 30, 2008 Female patient from JAPAN , 58 years of age, was diagnosed with hyperlipidaemia and was treated with Fluvastatin (View Usage). After Fluvastatin was administered, patient had the following side effects: retinal haemorrhage, visual acuity reduced. Fluvastatin dosage: 30 Mg/day.

5838923-9 | Weight Increased
on Jul 31, 2008 Female patient from JAPAN , 71 years of age, was treated with Fluvastatin (View Usage). Patient experienced the following unwanted or unexpected effects: weight increased. Fluvastatin dosage: 20 Mg/day. During the same period patient was treated with ACTOS (15 Mg Unk) (View Actos Review and Actos Label ), AMARYL (1 Mg Unk) (View Amaryl Review and Amaryl Label ).

5818993-4 | Asthenia, Burning Sensation, Confusional State, Dialysis, Dyspnoea, Hyperkalaemia, Hypertension, Renal Failure Acute
Patient was taking Fluvastatin (View Usage). Patient had the following side effects: asthenia, burning sensation, confusional state, dialysis (What is dialysis?), dyspnoea, hyperkalaemia, hypertension, renal failure acute on Jul 21, 2008 from UNITED STATES Additional patient health information: Male patient , weighting 175.5 lb, was diagnosed with hyperlipidaemia and. Fluvastatin dosage: 40mg Daily Po. During the same period patient was treated with GEMFIBROZIL (600mg Bid Po) (View Gemfibrozil Review and Gemfibrozil Label ). Patient was hospitalized.

5786823-5 | Polymyositis
Adverse event was reported on May 28, 2008 by a Female patient taking Fluvastatin (View Usage) (Dosage: ) . Location: FRANCE , 80 years of age, After Fluvastatin was administered, patient had the following side effects: polymyositis. During the same period patient was treated with HYDROXYCHLOROQUINE SULFATE (View Hydroxychloroquine Sulfate Review and Hydroxychloroquine Sulfate Label ), AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ).

5777342-0 | Myopathy, Myositis, Walking Disability
on Jun 11, 2008 Male patient from GERMANY , weighting 149.9 lb, was diagnosed with hypercholesterolaemia and was treated with Fluvastatin (View Usage). Patient experienced the following unwanted or unexpected effects: myopathy, myositis (What is myositis?), walking disability. Fluvastatin dosage: 80 Mg, Qd.

5775513-0 | Blood Creatinine Increased, Body Temperature Increased, Bradyphrenia, C-reactive Protein Increased, Convulsion, Incontinence, Loss Of Consciousness, Muscle Twitching
on Jun 06, 2008 Female patient from SWEDEN , 45 years of age, was treated with Fluvastatin (View Usage). Patient had the following side effects: blood creatinine increased, body temperature increased, bradyphrenia, c-reactive protein increased, convulsion, incontinence, loss of consciousness, muscle twitching. Fluvastatin dosage: 40 Mg/day. During the same period patient was treated with METOPROLOL TARTRATE (95 Mg/day) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), CIPRAMIL (40 Mg/day) (View Cipramil Review and Cipramil Label ), NEUROCIL (200 Mg/day) (View Neurocil Review and Neurocil Label ), TRIMIPRAMINE MALEATE (150 Mg/day) (View Trimipramine Maleate Review and Trimipramine Maleate Label ), TAXILAN (500 Mg/day) (View Taxilan Review and Taxilan Label ). Patient was hospitalized.

5764773-8 | Blood Creatinine Increased, Body Temperature Increased, Bradyphrenia, C-reactive Protein Increased, Convulsion, Incontinence, Loss Of Consciousness, Muscle Twitching
Patient was taking Fluvastatin (View Usage). After Fluvastatin was administered, patient had the following side effects: blood creatinine increased, body temperature increased, bradyphrenia, c-reactive protein increased, convulsion, incontinence, loss of consciousness, muscle twitching on Jun 06, 2008 from SWEDEN Additional patient health information: Female patient , 45 years of age, . Fluvastatin dosage: 40 Mg/day. During the same period patient was treated with BELOC (95 Mg/day) (View Beloc Review and Beloc Label ), CITALOPRAM HYDROBROMIDE (40 Mg/day) (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), NEUROCIL (200 Mg/day) (View Neurocil Review and Neurocil Label ), TRIMIPRAMINE MALEATE (150 Mg/day) (View Trimipramine Maleate Review and Trimipramine Maleate Label ), TAXILAN (500 Mg/day) (View Taxilan Review and Taxilan Label ). Patient was hospitalized.

5764674-5 | Blood Creatinine Increased, Body Temperature Increased, Bradyphrenia, C-reactive Protein Increased, Cerebral Disorder, Convulsion, Disorientation, Electroencephalogram Abnormal
Adverse event was reported on Jun 06, 2008 by a Female patient taking Fluvastatin (View Usage) (Dosage: 40 Mg Daily) was diagnosed with hyperlipidaemia and. Location: SWEDEN , 45 years of age, Patient experienced the following unwanted or unexpected effects: blood creatinine increased, body temperature increased, bradyphrenia, c-reactive protein increased, cerebral disorder, convulsion, disorientation, electroencephalogram abnormal. During the same period patient was treated with CITALOPRAM HYDROBROMIDE (40 Mg Daily) (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), TAXILAN (500 Mg Daily) (View Taxilan Review and Taxilan Label ), BELOC ZOK (95 Mg Daily) (View Beloc Zok Review and Beloc Zok Label ), NEUROCIL (200 Mg Daily) (View Neurocil Review and Neurocil Label ), TRIMIPRAMINE MALEATE (150 Mg Daily) (View Trimipramine Maleate Review and Trimipramine Maleate Label ). Patient was hospitalized.

5679298-8 | Blood Glucose Increased, Glycosylated Haemoglobin Increased, Pruritus, Rash
on Mar 19, 2008 Male patient from JAPAN , 85 years of age, was diagnosed with hypercholesterolaemia and was treated with Fluvastatin (View Usage). Patient had the following side effects: blood glucose increased, glycosylated haemoglobin increased, pruritus, rash (What is rash?). Fluvastatin dosage: 30 Mg Per Day. During the same period patient was treated with EUGLUCON (2.5 Mg, Unk) (View Euglucon Review and Euglucon Label ), BASEN (0.3 Mg, Unk) (View Basen Review and Basen Label ), MICARDIS (40 Mg, Unk) (View Micardis Review and Micardis Label ), NORVASC (2.5 Mg, Unk) (View Norvasc Review and Norvasc Label ), URIEF (4 Mg, Unk) (View Urief Review and Urief Label ), DEPAS (0.5 Mg, Unk) (View Depas Review and Depas Label ).

5662654-1 | Arthralgia, Blood Creatine Phosphokinase Increased, Cervicobrachial Syndrome, Epicondylitis, Muscle Rigidity, Muscle Spasms, Myopathy, Pain, Tenosynovitis
on Mar 10, 2008 Male patient from GERMANY , 61 years of age, was diagnosed with hypercholesterolaemia, hypertension and was treated with Fluvastatin (View Usage). After Fluvastatin was administered, patient had the following side effects: arthralgia, blood creatine phosphokinase increased, cervicobrachial syndrome, epicondylitis, muscle rigidity, muscle spasms, myopathy, pain (What is pain?), tenosynovitis. Fluvastatin dosage: 20 Mg, Qd. During the same period patient was treated with KARVEZIDE (View Karvezide Review and Karvezide Label ).

5655419-8 | Blood Glucose Increased, Glycosylated Haemoglobin Increased, Pruritus, Rash
Patient was taking Fluvastatin (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose increased, glycosylated haemoglobin increased, pruritus, rash (What is rash?) on Feb 26, 2008 from JAPAN Additional patient health information: Male patient , 85 years of age, was diagnosed with hypercholesterolaemia and. Fluvastatin dosage: 30 Mg Per Day. During the same period patient was treated with GLYBURIDE (2.5 Mg, Unk) (View Glyburide Review and Glyburide Label ), BASEN (0.3 Mg, Unk) (View Basen Review and Basen Label ), MICARDIS (40 Mg, Unk) (View Micardis Review and Micardis Label ), NORVASC (2.5 Mg, Unk) (View Norvasc Review and Norvasc Label ), URIEF (4 Mg, Unk) (View Urief Review and Urief Label ), DEPAS (0.5 Mg, Unk) (View Depas Review and Depas Label ).

5650753-X | Arthralgia, Blood Creatine Phosphokinase Increased, Cervicobrachial Syndrome, Epicondylitis, Muscle Rigidity, Muscle Spasms, Myopathy, Pain, Tenosynovitis
Adverse event was reported on Feb 28, 2008 by a Male patient taking Fluvastatin (View Usage) (Dosage: 20 Mg, Qd) was diagnosed with hypercholesterolaemia, hypertension and. Location: GERMANY , 61 years of age, Patient had the following side effects: arthralgia, blood creatine phosphokinase increased, cervicobrachial syndrome, epicondylitis, muscle rigidity, muscle spasms, myopathy, pain (What is pain?), tenosynovitis. During the same period patient was treated with KARVEZIDE (View Karvezide Review and Karvezide Label ).

5642846-8 | Blood Glucose Increased, Glycosylated Haemoglobin Increased, Pruritus, Rash
on Feb 19, 2008 Male patient from JAPAN , 85 years of age, was diagnosed with hypercholesterolaemia and was treated with Fluvastatin (View Usage). After Fluvastatin was administered, patient had the following side effects: blood glucose increased, glycosylated haemoglobin increased, pruritus, rash (What is rash?). Fluvastatin dosage: 30 Mg Per Day. During the same period patient was treated with GLYBURIDE (2.5 Mg, Unk) (View Glyburide Review and Glyburide Label ), BASEN (0.3 Mg, Unk) (View Basen Review and Basen Label ), MICARDIS (40 Mg, Unk) (View Micardis Review and Micardis Label ), NORVASC (2.5 Mg, Unk) (View Norvasc Review and Norvasc Label ), URIEF (4 Mg, Unk) (View Urief Review and Urief Label ), DEPAS (0.5 Mg, Unk) (View Depas Review and Depas Label ).

5635981-1 | Thrombotic Thrombocytopenic Purpura
on Feb 13, 2008 Male patient from JAPAN , 65 years of age, was treated with Fluvastatin (View Usage). Patient experienced the following unwanted or unexpected effects: thrombotic thrombocytopenic purpura. Fluvastatin dosage: 20 Mg/ Day.

5619805-4 | Abdominal Pain, Anorexia, Dehydration, Hypokalaemia, Muscular Weakness, Nausea, Pelvic Pain, Rash, Urinary Tract Infection
Patient was taking Fluvastatin (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), anorexia, dehydration, hypokalaemia, muscular weakness, nausea (What is nausea?), pelvic pain (What is pelvic pain?), rash (What is rash?), urinary tract infection (What is urinary tract infection?) on Jan 29, 2008 from UNITED STATES Additional patient health information: Female patient , 68 years of age, weighting 173.9 lb, was diagnosed with prophylaxis, osteoporosis postmenopausal and. Fluvastatin dosage: . During the same period patient was treated with RECLAST (5 Mg, Once/single) (View Reclast Review and Reclast Label ), VITAMIN D3 (View Vitamin D3 Review and Vitamin D3 Label ), CALCIUM GLUCONATE (View Calcium Gluconate Review and Calcium Gluconate Label ).